U.S. puts $1 billion toward development of H1N1 flu vaccine

05/25/2009 | Wall Street Journal, The

The HHS said the government is earmarking $1 billion to fund clinical trials this summer for an H1N1 swine flu vaccine and to produce two bulk components of the vaccine for stockpiling in case an extensive vaccination program is needed. The government agreed to provide funding to Novartis, Sanofi-Aventis and GlaxoSmithKline to manufacture the vaccine ingredients.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA